Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner
Abstract Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant...
Main Authors: | Abdallah Sharqawi, Naomi Drye, Abdul Shugaba, Alison O’reilly, Ahmed M. Kadry, A I El-Sakka |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12894-023-01241-6 |
Similar Items
-
PI‐RADS 3 score: A retrospective experience of clinically significant prostate cancer detection
by: Andrés Camacho, et al.
Published: (2023-07-01) -
Biparametric Prostate MRI Shows Similar Diagnostic Accuracy Rates for Prostate Cancer Detection with Multiparametric MRI
by: Faruk Yencilek, et al.
Published: (2022-09-01) -
The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
by: Paulius Aliukonis, et al.
Published: (2017-04-01) -
Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
by: Mehmet Coşkun, et al.
Published: (2021-02-01) -
Predictors of prostate cancer cetection in MRI PI-RADS 3 lesions – Reality of a terciary center
by: Débora Araújo, et al.
Published: (2023-12-01)